September 27, 2016 10:01 PM ET

Pharmaceuticals

Company Overview of Allergan, Inc.

Key Executives for Allergan, Inc.

NameBoard RelationshipsTitleAge
James M. Hindman 22 RelationshipsChief Financial Officer and Executive Vice President of Finance & Business Development55
James F. Barlow No RelationshipsPrincipal Accounting Officer, Senior Vice President and Corporate Controller57
Arnold A. Pinkston 11 RelationshipsExecutive Vice President, General Counsel, and Assistant Secretary57
Scott M. Whitcup M.D.58 RelationshipsChief Scientific Officer and Executive Vice President of Research & Development57

Allergan, Inc. Board Members*

NameBoard RelationshipsPrimary CompanyAge
Michael R. Gallagher 17 RelationshipsAllergan plc70
Russell T. Ray 48 RelationshipsHLM Venture Partners68
Trevor Mervy Jones CBE, Ph.D., DSc FKC FPS FRSC Hon FRCP FBPharmcolS 62 RelationshipsArthurian Life Sciences Ltd73
Henri A. Termeer 271 RelationshipsSanofi Biosurgery Inc.70
Louis J. Lavigne Jr. 155 RelationshipsAccuray Incorporated68
View All Board Members

Allergan, Inc. Executive Committees*

Committee NameChairpersonBoard RelationshipsMembers
Audit Committee Russell T. Ray48 Relationships4 Executives
Compensation Committee Michael R. Gallagher17 Relationships4 Executives
Corporate Governance Committee Henri A. Termeer271 Relationships4 Executives
Finance Committee Russell T. Ray48 Relationships4 Executives
Management/Organization Development Committee Michael R. Gallagher17 Relationships4 Executives
View Committee Details
*Data is at least as current as the most recent Definitive Proxy.
 

The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

CEO COMPENSATION IN THIS INDUSTRY

  Industry Range
Salary
405.9K
Bonus
514.1K
Total Short Term Compensation
594.9K
Total Value of Options
14.4M
Compensation as of Fiscal Year
Allergan, Inc. CEO Compensation
Industry Average

INDUSTRY EXECUTIVE CHANGES

Imprimis Pharmaceuticals, Inc. Announces the Resignation of William H. Nelson as Independent Director and from All Board Committee Positions, Effective Immediately
September 26, 2016 9:00 PM ET
Jounce Therapeutics, Inc. Appoints Stephen Farrand as Chief Technical Officer
September 26, 2016 1:11 PM ET
Nouscom Announces Management Appointments
September 26, 2016 6:00 AM ET
Tyche Industries Ltd Announces the Resignation of G Sandeep as Whole Time Director and Chief Financial Officer
September 24, 2016 12:00 AM ET
Endo International plc Announces Executive Changes
September 23, 2016 11:00 AM ET

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Allergan, Inc., please visit . Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.